Cargando…
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476419/ https://www.ncbi.nlm.nih.gov/pubmed/32895293 http://dx.doi.org/10.1136/openhrt-2020-001350 |
| _version_ | 1783579697144135680 |
|---|---|
| author | DiNicolantonio, James J Barroso-Arranda, Jorge McCarty, Mark |
| author_facet | DiNicolantonio, James J Barroso-Arranda, Jorge McCarty, Mark |
| author_sort | DiNicolantonio, James J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7476419 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74764192020-09-08 Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 DiNicolantonio, James J Barroso-Arranda, Jorge McCarty, Mark Open Heart Editorial BMJ Publishing Group 2020-09-06 /pmc/articles/PMC7476419/ /pubmed/32895293 http://dx.doi.org/10.1136/openhrt-2020-001350 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Editorial DiNicolantonio, James J Barroso-Arranda, Jorge McCarty, Mark Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 |
| title | Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 |
| title_full | Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 |
| title_fullStr | Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 |
| title_full_unstemmed | Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 |
| title_short | Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19 |
| title_sort | ivermectin may be a clinically useful anti-inflammatory agent for late-stage covid-19 |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476419/ https://www.ncbi.nlm.nih.gov/pubmed/32895293 http://dx.doi.org/10.1136/openhrt-2020-001350 |
| work_keys_str_mv | AT dinicolantoniojamesj ivermectinmaybeaclinicallyusefulantiinflammatoryagentforlatestagecovid19 AT barrosoarrandajorge ivermectinmaybeaclinicallyusefulantiinflammatoryagentforlatestagecovid19 AT mccartymark ivermectinmaybeaclinicallyusefulantiinflammatoryagentforlatestagecovid19 |